ABIONYX (EPA:ABNX) | WebDisclosure

PRESS RELEASE

published on 05/06/2025 at 21:33, 1 year 1 month ago

Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
ABIONYX Pharma communique le nombre de droits de vote et d'actions en circulation, conformément aux exigences de l'AMF. La société se consacre au développement de biomédicaments novateurs pour les maladies inflammatoires les plus sévères

Droits De Vote AMF Maladies Inflammatoires Biopharma ABIONYX Pharma
PRESS RELEASE

published on 05/06/2025 at 21:33, 1 year 1 month ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Monthly statement of total voting rights and shares for ABIONYX Pharma on Euronext Paris, including total gross and net voting rights as of April 30, 2025

Euronext Paris Shares Total Voting Rights ABIONYX Pharma April 30 2025
BRIEF

published on 03/21/2025 at 07:35, 1 year 3 months ago

CIC Market Solutions recommande l'achat de l'action ABIONYX Pharma

Achat Biopharma Traitements Innovants ABIONYX Pharma CIC Market Solutions
BRIEF

published on 03/21/2025 at 07:35, 1 year 3 months ago

CIC Market Solutions recommends purchasing ABIONYX Pharma shares

Purchase Biopharma Innovative Treatments ABIONYX Pharma CIC Market Solutions
PRESS RELEASE

published on 03/21/2025 at 07:30, 1 year 3 months ago

Informations privilégiées / Autres communiqués
ABIONYX Pharma bénéficie de l'initiation à l'achat par CIC Market Solutions, un service du Crédit Mutuel Alliance Fédérale, avec une recommandation à l'achat

Crédit Mutuel ABIONYX Pharma CIC Market Solutions Biopharmacie Recommandation Achat
PRESS RELEASE

published on 03/21/2025 at 07:30, 1 year 3 months ago

Inside Information / Other news releases
CIC Market Solutions initiates buy coverage of ABIONYX Pharma. ABIONYX Pharma, a next-generation biopharma dedicated to innovative biomedicines based on recombinant apoA-I for severe inflammatory diseases, receives Buy recommendation from CIC Market Solutions

Buy Recommendation Biopharma ABIONYX Pharma CIC Market Solutions Innovative Biomedicines
BRIEF

published on 02/28/2025 at 07:35, 1 year 3 months ago

ABIONYX renforce son engagement contre la Déficience LCAT

Autorisation De Mise Sur Le Marché Maladie Rare Déficience LCAT Biomédicament Maladie De Norum
BRIEF

published on 02/28/2025 at 07:35, 1 year 3 months ago

ABIONYX strengthens its commitment against LCAT Deficiency

Rare Disease Marketing Authorization LCAT Deficiency Biomedicine Norum Disease
PRESS RELEASE

published on 02/28/2025 at 07:30, 1 year 3 months ago

Informations privilégiées / Autres communiqués
ABIONYX s’engage dans la Déficience LCAT (Maladie de Norum) en soutenant les patients et préparant l'AMM, bénéficiant de la Désignation de Maladie Orpheline en Europe et aux USA

ABIONYX EMA Déficience LCAT Maladie De Norum Désignation Orpheline
PRESS RELEASE

published on 02/28/2025 at 07:30, 1 year 3 months ago

Inside Information / Other news releases
ABIONYX renews commitment to treat LCAT Deficiency (Norum's disease) and provides updates on advances, including submission of Marketing Authorization Application and Orphan Disease Designation

ABIONYX LCAT Deficiency Rare Disease Day Marketing Authorization Application Orphan Disease Designation

Published on 06/24/2026 at 16:30, 3 hours 12 minutes ago

Development Manager Appointed
Published on 06/24/2026 at 14:45, 4 hours 57 minutes ago

Amdocs Selected by Three Scandinavia to Support Customer Engagement Transformation Across Nordic Markets
Published on 06/24/2026 at 14:00, 5 hours 42 minutes ago

GameSquare and U.S. Army Partner for Soldier Showdown 8, Presented by USAA
Published on 06/24/2026 at 14:00, 5 hours 42 minutes ago

Adcore Announces Voting Results from Annual Shareholders Meeting
Published on 06/24/2026 at 13:05, 6 hours 37 minutes ago

Faraday Copper Reports Drill Results Including Near-Surface Copper Mineralization in the American Eagle Area

View all ACCESSWIRE

Published on 06/24/2026 at 18:29, 1 hour 13 minutes ago

Designated Person Notification
Published on 06/24/2026 at 18:29, 1 hour 13 minutes ago

Designated Person Notification
Published on 06/24/2026 at 18:25, 1 hour 17 minutes ago

Huawei Helps Global Carriers Monetize Tokens with Service-Network-Compute Integration
Published on 06/24/2026 at 18:25, 1 hour 17 minutes ago

Annual General Meeting of Highlight Event and Entertainment AG
Published on 06/24/2026 at 18:05, 1 hour 37 minutes ago

BOS GmbH & Co. KG: Admission of bonds to trading on the Luxembourg Stock Exchange

View all EQS

Published on 06/24/2026 at 19:00, 42 minutes ago

ALTAREA - Succès de l’option pour le paiement du dividende en actions : taux de souscription de 78,5 %
Published on 06/24/2026 at 18:00, 1 hour 42 minutes ago

Annual Results 2025-26
Published on 06/24/2026 at 18:00, 1 hour 42 minutes ago

CP résultats annuels 2025-26
Published on 06/24/2026 at 18:00, 1 hour 42 minutes ago

KERLINK : Assemblée générale mixte des actionnaires du 23 juin 2026 Seconde convocation le 9 juillet 2026.
Published on 06/24/2026 at 17:45, 1 hour 57 minutes ago

Air Liquide poursuit son développement au Kazakhstan avec un investissement clé pour le complexe industriel de Silleno

View all LES ECHOS COMFI WIRE

News